Abstract:Importance: Transplantation is one of the few areas in medicine where the definitive treatment is rationed. Subjective decision-making pose challenges towards the transplant selection process. It has been proposed that large language models (LLMs) as artificial intelligent (AI) agents could provide objectivity in decision-making to solve complex problems. Objective: To examine the performance of a multidisciplinary selection committee of AI agents (AI-SC) as a proof-of-concept towards objectivity in the liver transplant (LT) selection process. Design: The AI-SC consisted of four LLMs: transplant hepatologist, transplant surgeon, cardiologist, and social worker. Zero-shot prompting with chain-of thought was used. Decisions were made based on clinicodemographic characteristics at time of waitlisting and LT. Setting: National LT cohort. Participants: Adult patients receiving deceased donor LT from 2004-2023 were extracted from the Scientific Registry of Transplant Recipients (SRTR) and clinical vignettes were generated. Standard absolute contraindications to LT were randomly assigned to a subset of patients to expose the AI-SC to cases of patients declined for LT. Exposures: Clinicodemographic characteristics at waitlisting and transplantation. Main Outcomes and Measures: The AI-SCs accuracy with either: 1) listing candidates if LT would offer a 6-month or 1-year survival benefit or 2) declining candidates if contraindications to LT are present or if LT would not offer those survival benefits. Results: Of 8,412 patients, 83.6% were waitlisted and 16.4% had contraindications to LT. The AI-SC was able to accurately identify contraindications to LT (accuracy: 98.2%, 95%CI 97.9%-98.4%), predict 6-month (94.9%, 95%CI 94.4%-95.3%) and 1-year (92.0%, 95%CI 91.4%-92.6%) survival. HCC burden beyond Milan criteria was the most common reason for accepted patients who were declined by AI-SC (False Negative). Malignancy was the most common cause of death prior to 6-month or 1-year end points (False Positive). The AI-SC most frequently did not perceive a lack of social support or severe cardiopulmonary disease as barriers to LT. Conclusions and Relevance: LLMs can be leveraged to simulate the LT-SC meetings and provide accurate, objective insights on patients who may or may not benefit from LT. Lessons learned from this proof-of-concept are a provocative step towards making the LT selection process more equitable and objective.

Augmenting the Transplant Team With Artificial Intelligence: Toward Meaningful AI Use in Solid Organ Transplant

The transformative potential of artificial intelligence in solid organ transplantation

Beyond Human Limits: Harnessing Artificial Intelligence to Optimize Immunosuppression in Kidney Transplantation

Artificial Intelligence and Robotics in Transplant Surgery: Advancements and Future Directions

Proceedings of the 2024 Transplant AI Symposium

Artificial Intelligence in Liver Transplantation

Artificial Intelligence in Pediatric Liver Transplantation: Opportunities and Challenges of a New Era

Present and Future Applications of Artificial Intelligence in Kidney Transplantation

Artificial intelligence-based clinical decision support for liver transplant evaluation and considerations about fairness: A qualitative study

The emerging role of generative artificial intelligence in transplant medicine

The promise of machine learning applications in solid organ transplantation

Artificial intelligence, machine learning, and deep learning in liver transplantation

Artificial intelligence, big data and heart transplantation: Actualities

The AI Agent in the Room: Informing Objective Decision Making at the Transplant Selection Committee

Smart match: revolutionizing organ allocation through artificial intelligence

[Artificial intelligence in kidney transplant pathology]

Using Artificial Intelligence Resources in Dialysis and Kidney Transplant Patients: A Literature Review

Recent Advances in Artificial Intelligence to Improve Immunotherapy and the Use of Digital Twins to Identify Prognosis of Patients with Solid Tumors

Cherry on Top or Real Need? A Review of Explainable Machine Learning in Kidney Transplantation

Artificial Intelligence Approaches for Predicting the Risks of Durable Mechanical Circulatory Support Therapy and Cardiac Transplantation

Artificial Intelligence and liver: Opportunities and barriers